US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist

3.750
0.0000.00%

Close Aug 16 16:00 ET

3.820
+0.070+1.87%

Post 18:37 ET

997.85MMarket Cap-3289P/E (TTM)

Autolus Therapeutics Stock Forum

TrendTrader

May 1 13:26

I love when swings work right away

$Autolus Therapeutics (AUTL.US)$

TrendTrader

May 1 12:44

Looking good for a swing

$Autolus Therapeutics (AUTL.US)$

Meltyy

Mar 28 06:44

Upcoming Cell & Gene Therapy PDUFA’s in 2024

Several highly anticipated PDUFA decisions are approaching..👇
Abeona Therapeutics ( $Abeona Therapeutics (ABEO.US)$ )
Asset: Pz-cel (prademagene zamikeracel)
PDUFA Date: May 25, 2024
Indication: Recessive dystrophic epidermolysis bullosa (RDEB)
Technology: Autologous cell therapy, treatment uses gene transfer to deliver COL7A1 genes into an RDEB patient’s own skin cells then transplanting them back to the patient.
Rocket Pharmaceuticals ( $Rocket Pharmaceuticals (RCKT.US)$ )...

FANCY PANTS

Feb 24 18:43

Also on this week's watchlist

$Autolus Therapeutics (AUTL.US)$

Moomoo AI

Jan 10 06:07

The appointment of Robert W. Azelby, with his extensive experience and track record in building successful biotech companies, is seen as a valuable addition to Autolus's Board as the company moves closer to commercializing its first product.

Press Release: Autolus Therapeutics Announces the Appointment of Robert W. Azelby to Its Board of Directors

Moomoo AI

Dec 29, 2023 06:12

The significant increase in Autolus Therapeutics' share price and revenue growth has caught the market's attention, signalling optimism. However, despite recent positive returns, the company's long-term loss requires cautious investment consideration.

Autolus Therapeutics (NASDAQ:AUTL) Delivers Shareholders Strong 266% Return Over 1 Year, Surging 18% in the Last Week Alone

Moomoo AI

Dec 22, 2023 06:11

Dr. Christian Itin, CEO of Autolus, expressed optimism about Leiderman's appointment citing her vast financial, transaction, and operational experience. He also shared the company's anticipation to transition from a development stage to a commercial entity.

Press Release: Autolus Therapeutics Announces Changes to Its Board of Directors

Meltyy

Nov 22, 2023 03:59

Healthcare

Why Join Us?
Pre-market Magic: Wanna know the insider scoop before the market opens? Our talented crew will give you the lowdown on pre-market movements, giving you a sneak peek into the thrill of investing!
FDA Calendar Know-how: Confused about FDA approval processes? Fear not! Our FDA Calendar will turn you into a pharma whiz, keeping you in the loop with crucial timings!
Money Trail: Curious about where the funds are flowing? The Fundraising Tracker '23 is here to spill the beans, ...